| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |